chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I just don't feel like myself; Had sinus congestion; Coughed; My eyes hurt; Vomiting; Headache; My arm was really sore at the injection site; Tired; Flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), FEELING ABNORMAL (I just don't feel like myself), SINUS CONGESTION (Had sinus congestion), COUGH (Coughed) and EYE PAIN (My eyes hurt) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 29-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), SINUS CONGESTION (Had sinus congestion), COUGH (Coughed), EYE PAIN (My eyes hurt), VOMITING (Vomiting), HEADACHE (Headache), VACCINATION SITE PAIN (My arm was really sore at the injection site) and FATIGUE (Tired).   On 04-Feb-2021, the patient experienced FEELING ABNORMAL (I just don't feel like myself). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), FEELING ABNORMAL (I just don't feel like myself), SINUS CONGESTION (Had sinus congestion), COUGH (Coughed), EYE PAIN (My eyes hurt), VOMITING (Vomiting), HEADACHE (Headache), VACCINATION SITE PAIN (My arm was really sore at the injection site) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test positive: Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Injection site it was warm to the touch; Pain up to the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site it was warm to the touch) and ARTHRALGIA (Pain up to the shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site it was warm to the touch) and ARTHRALGIA (Pain up to the shoulder). At the time of the report, VACCINATION SITE WARMTH (Injection site it was warm to the touch) and ARTHRALGIA (Pain up to the shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reporter No treatment information were reported   Reporter did not allow further contact
Vomiting every other day since the second dosage of Moderna vaccine was taken  on 2/21/21.
thalamic cerebrovascular accident with left sided weakness; keratoconjunctivitis of the left eye; amaurosis fugax of the left eye; Information has been received from a lawyer regarding a case in litigation concerning a male patient(pt) of unknown age .The pt's medical history, concurrent conditions and concomitant medications were not provided. On or around 01-SEP-2015, the pt was vaccinated with zoster vaccine live(ZOSTAVAX)(dose, route of administration, anatomical location, lot#, expiration date were unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). In 2015 (reported as "shortly after receiving zoster vaccine live(ZOSTAVAX)"), pt suffered decreased vision and was diagnosed with amaurosis fugax of the left eye and keratoconjunctivitis of the left eye. Pt additionally experienced acute let sided weakness and numbness and was diagnosed with a thalamic cerebrovascular accident with left sided weakness. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt's symptoms have resulted in physical limitations not present prior to using zoster vaccine live(ZOSTAVAX). Pt also experiences mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the zoster vaccine live(ZOSTAVAX), pt sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live(ZOSTAVAX), pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live(ZOSTAVAX), pt has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.   The events amaurosis fugax of the left eye, keratoconjunctivitis of the left eye, thalamic cerebrovascular accident with left sided weakness were considered as disability. Upon internal review, amaurosis fugax of the left eye, thalamic cerebrovascular accident with left sided weakness were determined to be medically significant.
Muscle ache, right arm, 3first  days; vomited dinner day 2 and occasional nausea 2 more days; joint pains off and on for first few days; "Covid Arm" day 8, ongoing: baseball sized 6" diameter hot red rash around injection site, and swollen finger joint opposite (left) hand. Ongoing, but pain and redness in arm is subsiding; finger joint remains swollen, stiff, and painful. Probably not related, 2 wks duration  tendinitis left retro heel.
About 1 minute after giving vaccines patient fainted. Did not lose consciousness. Patient's vitals were taken and patient rested on exam table. Was given a glass of water and assessed by doctor.
Metal tasting inn mouth after shot as well as small case of Bell?s palsy in left side of face
Swelling under my armpit with bad pain. Armpit has a baseball size lump in the swelling region. Swelling on my neck above my collar bone about the size of golf ball. Pain also runs all down my arm to my wrist.
significant leakage from the sight of injection; This is a spontaneous report from a contactable Pharmacist. This Pharmacist reported similar events for two patients. This is 2nd of two reports.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, after administration of the vaccine, the pharmacist reported that two of their doctors had significant leakage from the sight of injection. This was a clear fluid leaking out of the sight of injection. The pharmacist knew this type of leaking fluid is a common occurrence with the flu vaccine, but the pharmacist wanted to ask if there is any particular guidance on what should be done in the case of this vaccine. The pharmacist asked if the doctors should get titers drawn up to determine if they need to get a 3rd dose or if they should go ahead and get the 3rd dose anyways. The outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021030291 same reporter/drug/event; different patient
Headache, Myalgia, Fever, NauseaVomiting, Pain at injection site Narrative: Per nurins report: "called to report adverse effects after receiving her Moderna Booster on 11/17/21. Employee complains of fever (102), headache, body ache, nausea and injection site tenderness. Symptoms began on 11/18/21. She presented to work 11/18/2021, however took leave 11/19/2021."
Pain in left arm with immediate onset, exacerbated my movement, never decreased in intensity even after 7 months. Induration palpated at the site on the left deltoid injection. Gradual decrease in the range of motion of left shoulder.
Patient fainted after vaccine administration. Patient started to recover then her eyes rolled back and she began shaking. EMS was called. Patient was evaluated by EMS and parents elected to transport patient to hospital.
Tecchydardia; This spontaneous case was received on 05-Jan-2022 from other non-healthcare professional (consumer) via Agency (reference number: SEQW22-00052) and concerned a 47-year-old, female patient.  The patient's concurrent condition included Mast cell activation syndrome. The patient's concomitant medications included Zyrtec (cetirizine hydrochloride) and cromolyn sodium, both used for an unreported indication.  On 12-Dec-2021, the patient was vaccinated at a Pharmacy with Afluria Quadrivalent (influenza vaccine; dose, route of administration, anatomical location: not reported) to prevent influenza. The batch number was not reported.   On 13-Dec-2021, reported as the next morning, after receiving Afluria Quadrivalent, the patient experienced tachycardia. The patient went to the emergency room (ER) in the late afternoon. She was treated with Metoprolol (metoprolol succinate) at an unspecified dose and was sent home.  On the same day, the patient recovered from the event.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: A 47-year-old female patient experienced tachycardia within one day after vaccination with Afluria Quadrivalent. Based on plausible temporal relationship, causality for the reported event is assessed as possibly related.; Sender's Comments: A 47-year-old female patient experienced tachycardia within one day after vaccination with Afluria Quadrivalent. Based on plausible temporal relationship, causality for the reported event is assessed as possibly related.
Increased redness around the injection site.  Denies any pain, red streaks to arm or from around site, swelling or discharge.
Information has been received from a physician concerning a 15 year old female student who the morning of 09-NOV-2010 received a dose of GARDASIL (lot number: 666163/0664Z) intramuscularly in her left arm. It was unknown if the patient sought medical attention. Follow up information has been received from a health professional reported the patient had not yet received the second dose of GARDASIL. She had a reaction to the first dose of GARDASIL. At the time of the report, the outcome was unknown. It was unknown if the patient sought medical attention. Follow up information has been received from a physician who reported that the patient received the second dose of GARDASIL on unreported time with no adverse problems reported. This is one of several reports from the same source. No further information is available.
Pt's mom came in on 1/20/11. She stated that child's (R) arm at injection site began to become red & itchy on 1/18/11. Examined site on 1/20/11. Red area - 4 cm x 3 cm, no raised, no warmth, no hard. NP also examined area. Advised to take BENADRYL, apply alternating warm & cold packs. Called mom 1/21/11 - area now less red, no itchy. Advised mom to call if area becomes larger, hot, hard.
Shivering, sweating, lightheadedness, dizziness when standing up, stomach upset, pain through the whole body. Symptoms were treated with TYLENOL and patient felt better after a few day.
Today received 3rd dose of Hepatitis series (FYI). On vaccination day, bled completely through clothes. About 1 1/2 hours later swelling on arm. Hard spot at injection site like if vaccine did not go in body. Applied hot & cold compresses could not move arm huge bruise. Sore for 3 to 4 days. Still sore and bruised. Has improved somewhat. Received pneumonia vaccine 5 years ago with no problem.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 18-NOV-2015 at time- 00:11, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 4.3 and 2.2 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE DUE TO THROMBOSIS OF UNSPECIFIED ARTERY 8/23/2022 -- RECURRENCE OF SAME SYMPTOMS
Severe skin reaction all over body appearing approximately 60 hours after 2nd dose. Started out as hives and quickly became more red in color and more ubiquitous. After appointment with PA-C, she thinks this is a systemic reaction to vaccine and prescribed prednisone and Zyrtec
Within 3 minutes of vaccination, pt fainted.  Immediately came to.  Monitored for 20 minutes and then released pt as mom was comfortable with pt being ok.  Pt experienced similar episode 2 years prior during x-rays.
Tenderness in armpit; Swelling in his armpit in the arm of the injection site; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness in armpit), PERIPHERAL SWELLING (Swelling in his armpit in the arm of the injection site) and MYALGIA (muscle pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced TENDERNESS (Tenderness in armpit), PERIPHERAL SWELLING (Swelling in his armpit in the arm of the injection site) and MYALGIA (muscle pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of every 4 to 6 hours and NAPROXEN SODIUM (ALEVE) for Muscle pain, at an unspecified dose and frequency. At the time of the report, TENDERNESS (Tenderness in armpit), PERIPHERAL SWELLING (Swelling in his armpit in the arm of the injection site) and MYALGIA (muscle pain) outcome was unknown.            No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-101705 (E2B Linked Report).; Sender's Comments:  MOD-2021-101705:Dose 1
Patient (daughter) reports onset of weakness, confusion and sleepiness on 10/13/17. Worsened over course of 2 days. Resolved Sunday 10/15/17.
Patient noticed symptoms when she awoke the morning following her injection. She c/o chills with low grade fever, low BP, nausea, headache, increased back pain, and  body aches. She had swelling to her right upper arm. There was localized erythematous area to right deltoid at injection site. Warmth and tenderness with palpation. Pt reports she felt real bad Tuesday and Wednesday. Symptoms began to improve Thursday, which is when she was able to come to clinic for evaluation. Pt had been taking ibuprofen as needed. She was advised by provider to continue taking ibuprofen as needed for pain/swelling and can alternate with Tylenol. Advised she may apply ice pack to injection site. Advised to call or return to clinic if symptoms do not resolve or if they worsen.
Client canceled second dose appointment.  Reported tight throat within 4 hours and "itchy body welts" the next day.
Developed a rash on 6/30. Rash would go away a few hrs later. Rash would show up again daily in different areas on her body and go away a few hrs later. This lasted for a total of 5 days.
Beginning around 6am on 5/8/21 I experienced moderate joint pain/body aches, fever, moderate nausea, mild headache, severe fatigue and mild weakness.  I took Tylenol and drank sips of water all day.  The fever broke over the night Saturday with the fatigue and some diarrhea continuing Sunday.  By Tuesday I felt much better and I was able to eat and move about normally.
CAN NOT BREATH; RASH ON  FACE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 14-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAY-2021, the subject experienced can not breath. On MAY-2021, the subject experienced rash on face. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash on face, and can not breath. This report was non-serious.
Screaming episode for 1-2 hours about 2 hours after vaccine administration c/o of feet hurting.
headache for over 7 days on and off Injection site soreness (unable to lift or sleep on arm) for 3 days muscle spasms at injection site for 2 hours, around 8 hours after injection Brain fog on going, over 8+weeks past injection, unable to focus and concentrate. noticeable by family and co workers
Patient test was collected on 01/20/2022 with positive covid results.  Patient had symptoms of acute respiratory distress.  Also cough, shortness of breath and fatigue.  She  has an underlying health condition of chronic lung disease. Patient was admitted on 01/20/22 and discharged the next day: 01/21/2022
Increased heart rate, lowered blood pressure, sneezing, coughing (2 hours after injection), severe fatigue/lethargy approximately 24 hours after injection. Also, chills and headache.
4/4/03: heartburn in AM, resolved after eating small portion of milk and crackers. 4/5/03: Awaken shortly after midnight with SOB, chest pain and diaphoresis. Transferred to ER, had V-tach episode in ER. Transferred to hospital.
Lower left row of teeth in severe pain; This is a spontaneous report from a contactable consumer (patient). A 58-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number was not reported, patient was 58-year-old at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 24Feb2021 at 09:00 AM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included diabetes. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications received by the patient within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19, since the vaccination, the patient was not tested for COVID-19. No allergies to medications, food, or other products were reported. On 25Feb2021 at 06:00 PM, the patient experienced lower left row of teeth in severe pain. No seriousness criteria were reported. No treatment received for event. The outcome of event was not recovered.  Information on the lot/batch number has been requested  Follow-up (19MAY2021): Follow-up attempts completed. No further information expected.
Patient fully vaccinated for COVID-19, admitted with COVID-19 PNA, SOB/cough; requiring o2. Patient on dexamethasone and remdesivir.
diarrhea; headaches; nausea; last night she didn't sleep much at all; couple of whelps on my arms; It looks like a rash and is hot to the touch; The swelling and itching I don't want to aggravate buy using soap or something.; The swelling and itching I don't want to aggravate buy using soap or something.; This is a spontaneous report from a contactable consumer reported for herself. A 51-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration date was not reported), second dose via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient previously received Sulfamides and erythromycin and experienced allergy. The patient's concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 on an unspecified date for covid-19 immunisation and experienced diarrhea, headaches, nausea, sleep unwell and shivering. On an unspecified date, patient had diarrhea the first day, had headaches, nausea and then last night she didn't sleep much at all. She was shivering all night. But did not have a fever. Had the first vaccine a month ago and the second one on Tuesday. Thursday, she woke up with a couple of whelps on her arms and then today they were blurring together. This seems to be getting worse. The swelling and itching she did not want to aggravate buy using soap or something. It looked like a rash and was hot to the touch. It wasn't going smaller; it was getting bigger. Patient was asking what she could for it. The first time was minimal symptoms, but the second time was even worse for patient. Clinical outcome of events as unknown.  No follow-up attempts are needed. No further information is expected.
face got itchy; This is a spontaneous report from a Pfizer-sponsored program from a contactable nurse (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 07Jan2021, the patient experienced face got itchy. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
noted red macular rash over LLQ and RLQ abdominal wall and lower back.  Also macular rash on R upper arm
Approximately 1 hour after swelling and pain in the upper arm. Later that afternoon, pain increased (painful to touch all over shoulder and upper arm), joint aches in elbow and wrist. Morning, swelling and redness (6inch by 4inch red patch) difficulty raising arm, lifting anything. Contacted Dr and was advised to take Benadryl and come in if it got worse or go to hospital if throat or tongue started to swell.
Mild arm pain appeared immediately. From 12am - 4am I experience severe chills (despite putting on multiple layers and blankets) that caused me shiver so severely I felt like I was convulsing. No position was comfortable when lying down and nothing made the chills better. I also felt dehydrated, which is unusual for me. From 4am - 6:30am the symptoms reversed and I got extremely hot and uncomfortable. At 8am I noticed a prominent red, warm patch of  swelling around the injection site.